# IN8BIO, Inc.: Form SCHEDULE 13D, filed Jan 2, 2026

- Company: [IN8BIO, Inc.](/companies/inab.md) (CIK 1740279)
- Form: SCHEDULE 13D
- Filed: 2026-01-02
- Accepted by EDGAR: Jan 2, 2026, 19:10 ET
- Period: not reported
- Accession: 0001682638-26-000002
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1740279/000168263826000002/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1740279/000168263826000002/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1740279/000168263826000002/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Jan 2, 2026.
Source: SEC EDGAR, the filing index for accession 0001682638-26-000002. Last ingested by Listed: Nov 5, 2026, 17:49 ET. No prices; not investment advice.